Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 645,477 |
|
|||||
| News | - | ||||||
| Day High | 0.498051 | Low High |
|||||
| Day Low | 0.46925 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| BioVie Inc | BIVI | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.0143 | -2.83% | 0.4911 | 12:32:55 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.498051 | 0.46925 | 0.498051 | 0.5054 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 1,601 | 645,477 | $ 0.4870481 | $ 314,378 | - | 0.445 - 8.69 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:33:53 | 10 | $ 0.488249 | USD |
BioVie Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 19.54M | 39.87M | - | 0 | -50.26M | -1.26 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
BioVie News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical BIVI Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.50 | 0.524 | 0.462 | 0.4919375 | 787,192 | -0.0089 | -1.78% |
| 1 Month | 0.5336 | 0.561 | 0.445 | 0.4945545 | 839,690 | -0.0425 | -7.96% |
| 3 Months | 1.06 | 3.31 | 0.445 | 1.41 | 2,782,825 | -0.5689 | -53.67% |
| 6 Months | 3.20 | 5.82 | 0.445 | 1.69 | 1,711,568 | -2.71 | -84.65% |
| 1 Year | 7.76 | 8.69 | 0.445 | 2.04 | 959,541 | -7.27 | -93.67% |
| 3 Years | 18.75 | 23.86 | 0.445 | 3.79 | 506,136 | -18.26 | -97.38% |
| 5 Years | 10.50 | 46.0977 | 0.445 | 4.32 | 434,943 | -10.01 | -95.32% |
BioVie Description
| BioVie Inc is a company developing innovative drug therapies to treat chronic debilitating conditions including liver disease and neurological and neuro-degenerative disorders and certain cancers. The company is currently focused on developing and commercializing BIV201, a novel investigational approach to the treatment of ascites due to chronic liver cirrhosis. BIV201 has the potential to improve the health of thousands of patients suffering from life-threatening complications of liver cirrhosis due to hepatitis, non-alcoholic steatohepatitis and alcoholism. |
